739 related articles for article (PubMed ID: 28281907)
1. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
[TBL] [Abstract][Full Text] [Related]
2. Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine.
Beran J; Van Der Meeren O; Leyssen M; D'silva P
Vaccine; 2016 May; 34(24):2686-91. PubMed ID: 27105563
[TBL] [Abstract][Full Text] [Related]
3. Antibody persistence and immune memory in adults, 15 years after a three-dose schedule of a combined hepatitis A and B vaccine.
Van Damme P; Leroux-Roels G; Crasta P; Messier M; Jacquet JM; Van Herck K
J Med Virol; 2012 Jan; 84(1):11-7. PubMed ID: 22052690
[TBL] [Abstract][Full Text] [Related]
4. [Vaccination against viral hepatitis A and B in adults aged over 40 years--antibody persistence and immune memory].
Chlibek R; Smetana J; Bostíková V; Splino M
Epidemiol Mikrobiol Imunol; 2011 Sep; 60(3):99-108. PubMed ID: 22132651
[TBL] [Abstract][Full Text] [Related]
5. Long-term immunogenicity and immune memory after two doses of the adult formulation of a combined hepatitis A and B vaccine in children 1 to 11 years of age.
van Damme P; Kafeja F; Van Der Wielen M; Leyssen M; Jacquet JM
Pediatr Infect Dis J; 2011 Aug; 30(8):703-5. PubMed ID: 21346683
[TBL] [Abstract][Full Text] [Related]
6. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
Avdicova M; Crasta PD; Hardt K; Kovac M
Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
[TBL] [Abstract][Full Text] [Related]
7. Lasting immune memory against hepatitis B in 12-13-year-old adolescents previously vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy.
Behre U; Van Der Meeren O; Crasta P; Hanssens L; Mesaros N
Hum Vaccin Immunother; 2016 Nov; 12(11):2916-2920. PubMed ID: 27653771
[TBL] [Abstract][Full Text] [Related]
8. Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents.
Beran J; Kervyn D; Wertzova V; Hobzova L; Tichy P; Kuriyakose S; Leyssen M; Jacquet JM
Vaccine; 2010 Aug; 28(37):5993-7. PubMed ID: 20637766
[TBL] [Abstract][Full Text] [Related]
9. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
10. Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years.
Van Herck K; Jacquet JM; Van Damme P
J Med Virol; 2011 Nov; 83(11):1885-91. PubMed ID: 21915861
[TBL] [Abstract][Full Text] [Related]
11. Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years.
Chlibek R; von Sonnenburg F; Van Damme P; Smetana J; Tichy P; Gunapalaiah B; Leyssen M; Jacquet JM
J Travel Med; 2011; 18(2):145-8. PubMed ID: 21366801
[TBL] [Abstract][Full Text] [Related]
12. The effects of booster vaccination on combined hepatitis A and hepatitis B vaccine in both anti-HBs and anti-HAV negative children 5-15 years after hepatitis B vaccine primary immunization.
Chen Y; Gu H; Cheng S; Shen L; Cui F; Wang F; Yao J; Xia S; Lv H; Liang X
Hum Vaccin Immunother; 2013 Apr; 9(4):898-902. PubMed ID: 23295964
[TBL] [Abstract][Full Text] [Related]
13. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
14. Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults.
Höhler T; Groeger-Bicanic G; Hoet B; Stoffel M
Vaccine; 2007 Feb; 25(8):1503-8. PubMed ID: 17097774
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
16. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
17. Immune memory to hepatitis B persists in children aged 7-8 years, who were vaccinated in infancy with 4 doses of hexavalent DTPa-HBV-IPV/Hib (Infanrix™ hexa) vaccine.
Van Der Meeren O; Bleckmann G; Crasta PD
Hum Vaccin Immunother; 2014; 10(6):1682-7. PubMed ID: 24637296
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
Gilca V; Sauvageau C; Boulianne N; De Serres G; Couillard M; Krajden M; Ouakki M; Murphy D; Trevisan A; Dionne M
Hum Vaccin Immunother; 2014; 10(8):2438-45. PubMed ID: 25424952
[TBL] [Abstract][Full Text] [Related]
20. Antibody persistence six years after two doses of combined hepatitis A and B vaccine.
Burgess MA; McIntyre PB; Hellard M; Ruff TA; Lefevre I; Bock HL
Vaccine; 2010 Mar; 28(10):2222-2226. PubMed ID: 20056187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]